Pulling SEC filings + quote and writing the call…

KALTURA INC
Next earnings Aug 5, 2026 (before open) · consensus $-0.01 EPS, $46.5M rev
Last earnings +5.8% on 2026-05-11
Cheap, cash-generative turnaround inching to breakeven — but flat growth and a stressed balance sheet cap the upside.
Price / Market cap $1.26 / $187M · Current
Kaltura is a classic near-breakeven turnaround trading at a rock-bottom 1.0x sales. The four-year loss trajectory is genuinely encouraging: net loss has narrowed from -$59.4M (FY2021) to -$12.1M (FY2025), operating income is nearly breakeven at -$4.96M (+79.4% YoY), and the business threw off $14.5M of operating cash flow on just $661K of capex. With a 70.6% gross margin and a $187M market cap, the equity is priced for stagnation — and there is real optionality in the AI pivot (the eSelf AI acquisition and the pending PathFactory deal reposition it toward 'agentic' rich-media). On the numbers alone, a cash-flow-positive SaaS name at 1x revenue is not expensive.
The problem is that everything above is offset by two hard limits. First, growth is effectively absent: revenue rose just +1.2% to $181M, and the FY2021→FY2025 arc ($165M→$181M) is a ~2%/yr crawl. A software business that can't grow the top line has no engine to compound its way out of an accumulated deficit of -$481M. Second, the balance sheet is thin to the point of fragile — stockholders' equity has collapsed 74% to $6.33M (liabilities/equity of 25x), current liabilities of $126M exceed current assets of $90.7M (a working-capital deficit), cash is only $27.5M, and $29.0M of debt (+833.6% YoY) is now current. The 10-K itself flags that meeting long-term liquidity may require 'additional indebtedness [or] additional equity financings... [which] may not be available on favorable terms, or at all,' plus concentrated Israel/geopolitical exposure.
Is KLTR a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $165M | $169M | $175M | $179M | $181M |
| Gross profit | $103M | $107M | $112M | $119M | $128M |
| Operating income | -$32.7M | -$56.4M | -$38.7M | -$24.1M | -$4.96M |
| Net income | -$59.4M | -$68.5M | -$46.4M | -$31.3M | -$12.1M |
| Diluted EPS | — | — | -$0.34 | -$0.21 | -$0.08 |
| Net margin | -36.0% | -40.6% | -26.5% | -17.5% | -6.7% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results filed; routine director/auditor ratifications
Q1 FY26: continued small revenue growth, still narrowing operating losses
Q1 FY26: continued small revenue growth, still narrowing operating losses
Annual proxy: board slate, pay and auditor up for shareholder vote
Other-event disclosure, likely tied to PathFactory deal progress
FY25 loss cut 61% to -$12M on $181M rev; buybacks, $29M debt now current
FY25 loss cut 61% to -$12M on $181M rev; buybacks, $29M debt now current
Officer/director change announced; leadership transition
Other-event disclosure filed; no material financial impact signaled
Sources: SEC EDGAR (CIK 0001432133, latest 10-Q filed 2026-05-11) · EODHD · Proprietary analysis · as of 7/3/2026, 11:37:47 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 7:37 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-26 | Manor Eyal Director | Sell | 8.82K @ $1.29 | $11.4K |
| 2026-06-25 | Manor Eyal Director | Sell | 34.6K @ $1.30 | $45.0K |
| 2026-06-24 | David Shay Director | Award | 133K | |
| 2026-06-24 | Faier Ronen Director | Award | 133K | |
| 2026-06-24 | Halevi-Davidov Naama Director | Award | 133K | |
| 2026-06-24 | Levandov Richard Director | Award | 133K | |
| 2026-06-24 | Manor Eyal Director | Award | 133K | |
| 2026-06-24 | Dracon Gregory C. Director | Award | 171K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.